Skip to Content
Merck

HPLC Analysis of Barbiturates on Ascentis® C18

HPLC Analysis of Barbiturates on Ascentis® C18 application for HPLC

Materials

related product

Product No.
Description
Pricing

Barbital

Ascentis® C18 HPLC Column

5 μm particle size, L × I.D. 15 cm × 4.6 mm

Secobarbital solution

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Phenobarbital solution

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Butabarbital solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Barbiturate Mix-5 solution

250 μg/mL each component in methanol, ampule of 1.0 mL, certified reference material, Cerilliant®

Pentobarbital solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Mephobarbital

United States Pharmacopeia (USP) Reference Standard

CONDITIONS

column

Ascentis C18, 15 cm x 4.6 mm I.D., 5 μm particles (581324-U)

mobile phase

[A] methanol; [B] water (50:50, A:B)

flow rate

1.0 mL/min

column temp.

35 °C

detector

UV, 214 nm

injection

10 μL

sample

as indicated in 65:35 water:methanol

Description

Analysis Note

Barbiturates are commonly abused and among the most widely tested compounds in clinical, forensic, or therapeutic drug monitoring applications. Shown here is the baseline separation of a set of barbiturates on an Ascentis C18 column. Highest grade HPLC solvents were used to supply low background interference and low particulate contamination for robust, trouble-free operation. Cerilliant and Sigma-Aldrich reference standards provided reliable identification and quantification.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany